About the Authors
Department of Surgical Sciences, Uppsala University, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden
The authors declare the following competing interest: A patent is filed (USA) for “LRP5 and LRP6 Receptors in Cancer Treatment,” number WO2005048913.
GW designed the study. PB performed experiments and analyzed data. PB, GÅ, and GW interpreted the data. GÅ reviewed clinical data. PB, GÅ, and GW contributed to writing the paper.